Xu H - Search Results

1

Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.

Tang K, Li H, Xia D, Hu Z, Zhuang Q, Liu J, Xu H, Ye Z. Tang K, et al. Among authors: xu h. PLoS One. 2014 May 16;9(5):e95667. doi: 10.1371/journal.pone.0095667. eCollection 2014. PLoS One. 2014. PMID: 24835573 Free PMC article. Review.

2

LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.

Li F, Yang W, Guo D, Hu Z, Xu H, Ye Z. Li F, et al. Among authors: xu h. Oncol Rep. 2011 Jun;25(6):1629-37. doi: 10.3892/or.2011.1227. Epub 2011 Mar 22. Oncol Rep. 2011. PMID: 21431282

3

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.

Li H, Yu G, Shi R, Lang B, Chen X, Xia D, Xiao H, Guo X, Guan W, Ye Z, Xiao W, Xu H. Li H, et al. Among authors: xu h. Mol Cancer. 2014 Jan 15;13:8. doi: 10.1186/1476-4598-13-8. Mol Cancer. 2014. PMID: 24423412 Free PMC article.

4

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.

Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K, Zeng J, He W, Zeng G, Ye Z, Xu H. Xiao H, et al. Among authors: xu h. Oncol Rep. 2014 Apr;31(4):1832-8. doi: 10.3892/or.2014.3048. Epub 2014 Feb 24. Oncol Rep. 2014. PMID: 24573354

5

miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.

Yu G, Li H, Wang J, Gumireddy K, Li A, Yao W, Tang K, Xiao W, Hu J, Xiao H, Lang B, Ye Z, Huang Q, Xu H. Yu G, et al. Among authors: xu h. J Urol. 2014 Oct;192(4):1229-37. doi: 10.1016/j.juro.2014.05.094. Epub 2014 May 24. J Urol. 2014. PMID: 24866595

6

Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.

Dai J, Tang K, Xiao W, Yu G, Zeng J, Li W, Zhang YQ, Xu H, Chen ZQ, Ye ZQ. Dai J, et al. Among authors: xu h. Asian Pac J Cancer Prev. 2014;15(8):3369-75. doi: 10.7314/apjcp.2014.15.8.3369. Asian Pac J Cancer Prev. 2014. PMID: 24870724 Free article. Review.

7

Laparoscopic renal cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal masses: a systematic review and meta-analysis of comparative studies.

Tang K, Yao W, Li H, Guo X, Guan W, Ma X, Zhang X, Zeng G, He W, Xu H, Ye Z. Tang K, et al. Among authors: xu h. J Laparoendosc Adv Surg Tech A. 2014 Jun;24(6):403-10. doi: 10.1089/lap.2013.0550. J Laparoendosc Adv Surg Tech A. 2014. PMID: 24914926 Review.

8

The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.

Wang T, Liu Z, Guo S, Wu L, Li M, Yang J, Chen R, Xu H, Cai S, Chen H, Li W, Wang L, Hu Z, Zhuang Q, Xu S, Wang L, Liu J, Ye Z, Ji JY, Wang C, Chen K. Wang T, et al. Among authors: xu s, xu h. Oncotarget. 2014 Jun 15;5(11):3611-21. doi: 10.18632/oncotarget.1968. Oncotarget. 2014. PMID: 25003983 Free PMC article.

9

Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.

Xiao W, Wang J, Li H, Xia D, Yu G, Yao W, Yang Y, Xiao H, Lang B, Ma X, Guo X, Guan W, Xu H, Liu J, Zhang X, Ye Z. Xiao W, et al. Among authors: xu h. BMC Cancer. 2014 Sep 18;14:677. doi: 10.1186/1471-2407-14-677. BMC Cancer. 2014. PMID: 25234557 Free PMC article.

10

Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.

Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K, Ye Z, Huang Q, Xu H. Yu G, et al. Among authors: xu h. Mol Cancer Ther. 2014 Dec;13(12):3086-97. doi: 10.1158/1535-7163.MCT-14-0245. Epub 2014 Sep 23. Mol Cancer Ther. 2014. PMID: 25249556 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,467 results

Search Page

Filters